772
Participants
Start Date
March 31, 2012
Primary Completion Date
September 30, 2014
Study Completion Date
January 31, 2017
Oxaliplatin+S-1
S-1: 40\~60mg bid，po, d1\~14 （S-1：BSA \<1.25m2, 40mg bid, 1.25m2≤BSA≤1.5m2,50mg bid, BSA\>1.5m2, 60mg bid） oxaliplatin：130mg/m2，iv drip for 2h，d1
Adjuvant Oxaliplatin/S-1（SOX）
S-1：40\~60mg bid，d1\~14 q3W oxaliplatin：130mg/m2，iv drip for 2h，d1,q3W 8 cycles (6 months)
RECRUITING
Chinese PLA General Hospital, Beijing
Lead Sponsor
Lin Chen
OTHER